News


Characterization of Dry Powder Inhaler Performance

September 16, 2022
Dr. Conor Ruzycki, an Aerosol Engineer here at Lovelace Biomedical, has recently published his article titled: Characterization of Dry Powder…

Lovelace Biomedical will be Presenting Data on the Non-clinical and Clinical Development Work for HFA-152a at the Upcoming RDD Meeting

April 22, 2022
Lovelace Biomedical is excited to be presenting data on the non-clinical and clinical development work for HFA-152a at the upcoming…

Hammad Irshad – Using a Degree in Engineering to Make a Difference in Public Health

August 1, 2021
Hammad has 18 years experience, and focuses on our aerosol development and delivery for novel therapies. Hammad, tell me what you do…

PCR Development, it’s Uses, and Important Research at Lovelace Biomedical, with Bryan Gullick, PhD, Bioanalytical Research Scientist

July 4, 2021
Staff Spotlight: Bryan Gullick, PhD, Research Scientist Bryan Gullick, PhD, Bioanalytical Research Scientist Bryan, tell us about PCR in the development and…

Preclinical Drug Development for a Gene Therapy Product: No Cookie Cutter Route

June 1, 2021
Follow these critical steps on your path to IND application. By Philip J. Kuehl, PhD, Senior Scientist and Director of Scientific…

2020: The Year of the Scientist

January 12, 2021
2020 was the year of the scientist. In a culture where we primarily celebrate the accomplishments of artists or the…

Lovelace Biomedical Staff Spotlight: Tracylyn Yellowhair – Intra-tracheal (IT) Atomization of IT Liquid Delivery of a Test Article

January 1, 2021
As translational researchers we’re faced with many challenges in determining the best routes and methods for delivering inhaled therapeutics that…

From our Blog: Expert Pre-Clinical Toxicology – There is No Standard Template!

December 31, 2020
2019’s ACT meeting in Phoenix, AZ was the 40th Annual Meeting and brought some key highlights to the Lovelace Biomedical…

Are You Getting The Most out of Your Scientific Meeting Attendance?

October 12, 2020
Thinking about Scientific and professional development. As I reflect upon 2019 and the different trade shows I attended over 2019, it was…

Lovelace Biomedical Staff Spotlight: Janet Benson, Senior Scientist

December 12, 2019
Today’s staff spotlight belongs to Janet Benson. Janet is one of Lovelace’s longest tenured scientist, with decades of experience and…

Post Meeting Thoughts from the North American Cystic Fibrosis Conference (NACFC)

September 12, 2019
It was reinvigorating to get out from behind the desk, and out of the lab this past weekend to attend…

Traumatic Brain Injury – Collaborative Translational Science at Lovelace Biomedical and the Mind Research Network

August 12, 2019
Traumatic Brain Injury (TBI) is just one of the many areas of scientific study Lovelace Biomedical, along with its sister…

Lovelace Biomedical Staff Spotlight: Adam Werts – Veterinary Research Scientist

August 1, 2019
Today, we put the spotlight on Adam Werts. Adam recently joined Lovelace Biomedical as part of our veterinary research team.…

Updating My Business Plan for Competitive Landscape in the CRO Industry – What a Task!

July 14, 2019
– Jacob McDonald, CSO – Lovelace Biomedical Last summer, I wrote a business plan for Lovelace Biomedical. It aimed at…

“Beyond Standing Room Only” – Thoughts on the 22nd Annual Meeting of the Society of Gene and Cell Therapy – Dr. Janet Benson

June 27, 2019
As someone who has watched the ASGCT conference grow fairly steadily over the last 11 years, the growth in meeting attendance…

RT-PCR Validations: Square Peg/Round Hole?

June 1, 2019
Jacob McDonald, CSO – Lovelace Biomedical I set a disclaimer right away, in that I have been called a jack…

Lovelace’s Director of Bioanalytical Operations, Larry Mallis to be on hand to present poster at ASMS 2019 annual conference

May 30, 2019
Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference in Atlanta…

Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month

April 29, 2019
May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and has been…

BIOCHEMISTRY

April 26, 2019
Biochemistry or biological chemistry is a branch of biology and chemistry involving intense study of different chemical processes taking place…

BIOINFORMATICS

April 25, 2019
Bioinformatics involves in-depth understanding of biological data through strategic development of appropriate software tools. This is an interdisciplinary field including…

CELL BIOLOGY

April 24, 2019
Cell biology is the intense study of structure, composition, physiology and functioning of cells which is the most fundamental unit…

DRUG DESIGN

April 23, 2019
Preclinical Drug Design or Rational Drug Design is the process of discovering medications. The process of drug design is carried out…

MOLECULAR BIOLOGY

April 22, 2019
Molecular Biology is a branch of biology that understands and analysis the molecular structure, composition and functioning of cellular molecules.…

PHARMACEUTICS

April 19, 2019
Pharmaceutics is one of the divisions of pharmacy. It involves dealing with New Chemical Entities or drugs that are safely…

SCIENTIFIC RESEARCH

April 18, 2019
Scientific research is the sequential process of data collection, interpretation, analysis and reporting done in order to make contributions to…

PRECLINICAL RESEARCH

April 17, 2019
Preclinical research also known as preclinical study or preclinical development is the phase of research conducted prior to clinical trials.…

TOXICOLOGY

April 16, 2019
Preclinical Toxicology Research – Toxicology is the process of analyzing and understanding the effects of toxic chemical substances when injected into…

BIOTECHNOLOGY

April 15, 2019
Biotechnology is an extensive part of biology involving the development of technically advanced tools and techniques for use in biological…

Q & A with Audrey Yarbrough, Lovelace’s Senior Quality Assurance Specialist

April 10, 2019
Audrey will be attending and presenting at the 35th Annual Society of Quality Assurance Conference in Atlanta, GA April 28…

The FDA’s Guidance for Industry on Bioanalytical Method Validation, and us.

March 27, 2019
My thoughts, post WRIB annual conference – Larry Mallis, Director of Bioanalytical Operations At the recent WRIB meeting, my friends…

Who Are You Anyways?

March 20, 2019
Just a short while back I was in my final stretch of a marathon 31 meetings at the annual Society…

Not bigger, just better…

March 13, 2019
Holy cow, it is embarrassing to think that when I was a kid we had that slogan printed on our…

Is There a Place for “Mom & Pop” Toxicology Laboratories?

March 6, 2019
I always thought that a Mom-and-Pop designation best fit a small bakery or perhaps a hardware store.  Sort of like “Cheers,”…

Gene Therapy Saved Me – Lovelace Biomedical’s CSO recalls what gene therapy research has done not only for the company, but for himself as well

March 5, 2019
Gene Therapy Saved Me. I mean, not literally…but certainly from a figurative standpoint. In 2016 I took on the task…

THE PATH TO NEW GENE THERAPY: 7 Steps to IND

February 1, 2019
An increasing number of pharmaceutical and biotech companies are seeking expert help to navigate investigational gene therapies through preclinical studies With…

Putting the Science First – Dr. Jacob McDonald

January 31, 2019
Our CSO, Dr. Jacob McDonald discusses the evolving CRO market, emerging trends in preclinical research and how Lovelace keeps innovation…

Q & A With Dr. Meghan Vermillion, DVM – Who will be speaking at the 2019 ASM Biothreats Conference about Infectious Diseases

January 10, 2019
Catch Lovelace’s Dr. Meghan Vermillion speaking at the 2019 ASM Biothreats annual conference, which is happening January 29-31. We sat down…

Lovelace Expands Veterinary Expertise with New Hires

January 4, 2019
Top veterinary talent is at the core of preclinical success. And the more complex the study, the more important that…

A Culture of Continuous Improvement: The Lovelace Approach to Quality

January 1, 2019
The best-run preclinical research programs are just as devoted to strong science and achieving experimental objectives as they are to…

Focus on Infectious Disease: Reducing the Threat of ‘Flu-Imposter’ Adenovirus

December 13, 2018
It may feel like the flu — and be just as grave of a health threat — but it’s not…

Lovelace Discovers Novel Approach to Overcome Limitations of Nucleoside Assays

December 13, 2018
Nucleoside analogues are an essential component of many chemotherapies, anti-bacterial drugs and anti-viral agents. These compounds can play a key…

Lovelace’s Novel Nucleoside LCMS Assay to Be Presented at 12th Workshop on Regulations in Bioanalysis

April 1, 2018
Increasingly, biopharmaceutical companies are developing nucleoside analogues as chemotherapeutic, anti-bacterial and anti-viral agents. Of the nucleoside analogues in development, 5-azacytidine…

The Tox Factor: 4 Tips for Drug Sponsors Seeking a Toxicology Partner

March 31, 2018
Toxicology is often called the “science of safety,” and for good reason. The field is essential in moving potential new…

Existing Molecules Find New Calling as Medical Countermeasures

March 22, 2018
Innovation is percolating around new approaches to treating injuries that result from chemical, biological, radiological and nuclear defense, as well…

Old Drug, New Tricks: Lovelace Paves Fresh Path for Approved Cancer Therapy

March 13, 2018
The established cancer drug topotecan may hold promise as a more targeted therapy for patients with small-cell lung cancer (SCLC),…

Animal Behavioral Management Is Core to Preclinical Success

October 9, 2017
For preclinical pharmacology and toxicology studies to succeed, it’s essential that investigators and their teams use best practices for animal…

The Less Cough, the Better: Lovelace Biomedical, Novartis Research Collaboration Aims to Improve Inhaled Drugs

October 3, 2017
Inhaled medicines play an essential role in treating respiratory conditions and many other diseases, from pulmonary fibrosis to asthma. However,…

Lovelace Research Spotlight: Aerosol-Delivered Gene Therapy for Cystic Fibrosis

September 28, 2017
In a key study published in Human Gene Therapy Clinical Development, Lovelace Biomedical researchers found that delivering AAV gene therapy for…

Nose-Only Inhalation of microRNA Shows Promise for Pulmonary Fibrosis

September 21, 2017
Lovelace Biomedical designed a nose-only inhalation exposure system to evaluate an investigational microRNA-based therapy for pulmonary fibrosis — and through…

Overcoming Preclinical Hurdles in Rare Disease Research

September 14, 2017
For pharmaceutical and biotech companies, rare diseases present huge market opportunities — but also, potentially daunting development challenges. Incentivized by…

qPCR: The Weapon of Choice for Gene and Cell Therapy Biodistribution

September 7, 2017
To advance a gene or cell therapy product into clinical trials, drug developers must first gain a thorough understanding of…

Lovelace Radiation Research in the Spotlight at National Convention

August 31, 2017
Lovelace Biomedical’s scientific team will share two recent examples of their advanced preclinical work in defining animal models for radiation…

The Tools and Talent to Investigate the Flu: A Unique CRO Capability

August 24, 2017
It was nearly a century ago, in 1918, that an influenza pandemic swept the world, killing as many as 40…

FEATURED WEBINAR: Innovation in Aerosol Drug Formulations

August 17, 2017
Get an inside look into a 15-year collaboration between the scientists at Lovelace Biomedical and engineers at Capsugel, a company…

Breathe Easy: Meeting the Preclinical Challenges of Pulmonary Fibrosis

August 10, 2017
The race is on for better therapies to treat pulmonary fibrosis, a chronic lung disease characterized by irreversible scarring of…

Lovelace Biomedical Featured in The Scientist: Why Pharma Should Consider Canine Models for Alzheimer’s

August 3, 2017
The Scientist magazine recently featured an opinion article from Lovelace Biomedical Senior Scientist Edward Barrett, Ph.D., who shared his research that…

Lovelace Biomedical’s Advances in Toxicological Research to be Featured at the 56th Annual Meeting of the Society of Toxicology

March 8, 2017
Albuquerque, N.M., March 8, 2017 – Lovelace Biomedical, a not-for-profit preclinical contract research organization, today announced its participation in and presentation…

A Rich History, An Exciting Future

February 1, 2017
As you prepare to launch ambitious new projects in 2017, I’d like to personally encourage you to explore the wide…

Lovelace Biomedical to showcase expertise in inhalation drug delivery as hosts of the International Society of Aerosols in Medicine Congress

January 25, 2017
The Lovelace Respiratory Research Institute, including the commercially-focused CRO arm Lovelace Biomedical, has been a leader in inhalation drug delivery,…

Lovelace Biomedical Welcomes Larry Mallis, Ph.D. as Director of Bioanalytical Operations and Further Expands Bioanalytical Chemistry Capabilities

January 18, 2017
Lovelace Biomedical welcomes Dr. Larry Mallis as Director of Bioanalytical Operations and a key member of the scientific leadership team. …

Addressing the Preclinical Development Challenges of Gene Therapy

December 17, 2015
While the concept of gene therapy has been around for decades, gene therapy companies are just beginning to convert the…

European Style Housing of Nonhuman Primates

December 3, 2015
In the United States, laboratory animal research requirements are defined by a combination of the Animal Welfare Act Regulations (AWAR),…

Reflections on the state of the CRO Industry

October 13, 2015
Mimicking the decade-long trend of consolidation in the pharmaceutical industry, the past two years have seen a series of major…